Fucà, Giovanni
Guarini, Vincenzo
Antoniotti, Carlotta
Morano, Federica
Moretto, Roberto
Corallo, Salvatore
Marmorino, Federica
Lonardi, Sara
Rimassa, Lorenza
Sartore-Bianchi, Andrea
Borelli, Beatrice
Tampellini, Marco
Bustreo, Sara
Claravezza, Matteo
Boccaccino, Alessandra
Murialdo, Roberto
Zaniboni, Alberto
Tomasello, Gianluca
Loupakis, Fotios http://orcid.org/0000-0001-9651-0395
Adamo, Vincenzo
Tonini, Giuseppe
Cortesi, Enrico
de Braud, Filippo
Cremolini, Chiara
Pietrantonio, Filippo
Article History
Received: 25 January 2020
Revised: 3 April 2020
Accepted: 22 April 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: Institutional review board and ethics committee approval was obtained from all participating centres. All the patients provided written informed consent before any study-related procedures. The study was conducted in accordance with the Declaration of Helsinki.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: F.M. reported honoraria from: Servier; travel grants from: Sanofi, Servier. S.L. reported consulting/advisory board fees from: Amgen, Merck–Serono, Lilly; lecture fees from: Roche, Lilly, Bristol-Myers Squibb, Servier, Merck–Serono; research Funding: Amgen, Merck–Serono. L.R. reported consulting/advisory board fees from: Amgen, Arqule, Basilea, Baxter, Bayer, Celgene, Eisai, Exelixis, Hengrui, Incyte, Ipsen, Italfarmaco, Eli Lilly, MSD, Roche, Sanofi, and Sirtex Medical; lecture fees from: AbbVie, AstraZeneca, and Gilead; travel grants from: Arqule and Ipsen. A.S.B. reported consulting/advisory board fees from: Amgen, Bayer, Sanofi; lecture fees from: Amgen, Bayer, Sanofi; travel grants from: Amgen, Bayer, Sanofi. M.C. reported lecture fees from: Sanofi, Aventis, Amgen; travel grants from: Roche, Genentech, Sanofi, Aventis. A.Z. reported consulting/advisory board fees from: Amgen, Servier, Bayer, Merck–Serono; lecture fees from: Servier. F.L. reported consulting/advisory board fees from: Amgen, Sanofi, Bayer; lecturer fees from: Roche, Sanofi, Bayer, Amgen; institutional research funding from: Roche, Merck–Serono, Amgen, Bayer; travel grants from: Roche, Amgen, Merck–Serono. F.d.B. reported receiving honoraria for speaker activities and participation in advisory boards from: Amgen, Inc, Roche, and Novartis International AG. C.C. reported receiving honoraria for speaker activities and participation in advisory boards from: Roche, Amgen, Inc, Bayer AG, and Servier Laboratories; research grants from: Merck–Serono. F.P. reported receiving honoraria for speaker activities and participation in advisory boards from: Sanofi SA, Amgen, Inc, Bayer AG, Merck–Serono, Roche, and Servier Laboratories. All remaining authors have declared no conflicts of interest.
: The present study was funded by institutional funds from the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano.